login / register

Deals, Deals, Deals ... in a bear market - Part 45

New deals are being announced on a daily basis at the moment, with the pharmaceutical sector one of the most buoyant for dealmaking.

The latest deal is GlaxoSmithKline's takeover of Canadian biopharmaceutical company Bellus Health for $14.75 a share or around £1.6 billion.

That price is double Bellus Health's closing price of $7.26!

Below is a link to the press release if you want to read all the detail of the deal:..

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Tuesday, 18 April 2023, 8:20 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation